This paragraph stands outEven with its strong financial performance, HITI is still undervalued relative to its peers. I analyzed 12 other cannabis companies in order to get a snapshot of the industry for comparison multiples. Of these companies, the average Total Enterprise Value to Total Revenues LTM was 5.9x. By multiplying this multiple by HITI's Total Revenues LTM, we are left with an implied Enterprise Value of USD $575.84 million. After removing debt, adding cash, and dividing by shares outstanding, HITI has an implied share price of USD $12.8, a 92.5% increase from its last closing price of $6.65. For comparison, the same methodology produces implied share prices of $5.1 and $6.5 for TLRY and CGC, respectively. At last closing, TLRY stood at $11.52 and CGC closed at $13.12, implying heavy overvaluation relative to their industry. HITI's price point is even more favorable when you use Revenue forecasts for the next twelve months. Based on these forecasts and industry multiples, HITI has an implied share price of $16.67, TLRY of $4.57, and CGC of $5.15.